Patents by Inventor Max Davidson

Max Davidson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRPV1 EPITOPES AND ANTIBODIES
    Publication number: 20240052027
    Abstract: The present invention relates to antibodies that bind to TRPV1. The invention also relates to certain epitopes of the protein TRPV1. The invention also relates to immunoconjugates and compositions comprising such antibodies. The invention also provides methods of producing such antibodies. The invention further provides the use of such antibodies for therapeutic purposes, for example in the treatment of pain.
    Type: Application
    Filed: December 10, 2021
    Publication date: February 15, 2024
    Inventors: Carolina TRKULJA, Max DAVIDSON, Owe ORWAR
  • TRPV1 EPITOPES AND ANTIBODIES
    Publication number: 20230322916
    Abstract: The present invention relates to antibodies that bind to TRPV1. The invention also relates to certain epitopes of the protein TRPV1. The invention also relates to immunoconjugates and compositions comprising such antibodies. The invention also provides methods of producing such antibodies. The invention further provides the use of such antibodies for therapeutic purposes, for example in the treatment of pain.
    Type: Application
    Filed: December 10, 2020
    Publication date: October 12, 2023
    Inventors: Carolina TRKULJA, Max DAVIDSON, Owe ORWAR
  • KRAS EPITOPES AND ANTIBODIES
    Publication number: 20230109318
    Abstract: The present invention relates to antibodies that bind to certain oncogenic mutant forms of KRAS. The invention also relates to certain epitopes of oncogenic mutant forms of KRAS. The invention also relates to immunoconjugates and compositions comprising such antibodies. The invention also provides methods of producing such antibodies. The invention further provides the use of such antibodies for therapeutic purposes, for example in the treatment of cancer.
    Type: Application
    Filed: February 24, 2021
    Publication date: April 6, 2023
    Applicant: OBLIQUE THERAPEUTICS AB
    Inventors: Carolina TRKULJA, Max DAVIDSON, Owe ORWAR
  • Multi-protease method
    Patent number: 11408883
    Abstract: The present invention relates to methods of identifying an epitope on a protein that can be bound by an antibody. Methods of the invention typically involve a step of limited or restricted proteolysis of a protein using a single first protease or a combination of first proteases, and a further proteolysis step using a single second protease or combination of second proteases. The invention also relates to identified epitopes and to antibodies which bind to epitopes that have been identified by methods of the invention.
    Type: Grant
    Filed: October 6, 2017
    Date of Patent: August 9, 2022
    Assignee: OBLIQUE THERAPEUTICS AB
    Inventors: Owe Orwar, Carolina Trkulja, Max Davidson, Jessica Hägglund
  • THIOREDOXIN REDUCTASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER
    Publication number: 20210038577
    Abstract: The present invention provides inhibitors of thioredoxin reductase, in particular selenium compromised thioredoxin reductase-derived apoptotic protein (SecTRAP) forming agents, for use in treating an immune cell infiltrated cancer (e.g. a T-cell infiltrated cancer) in a subject, wherein said agents stimulate an anti-cancer immune response. The present invention also provides combinations comprising a SecTRAP forming agent and other therapeutic agents for use in treating cancer.
    Type: Application
    Filed: February 12, 2019
    Publication date: February 11, 2021
    Inventors: Owe Orwar, Max Davidson
  • MULTI-PROTEASE METHOD
    Publication number: 20200041499
    Abstract: The present invention relates to methods of identifying an epitope on a protein that can be bound by an antibody. Methods of the invention typically involve a step of limited or restricted proteolysis of a protein using a single first protease or a combination of first proteases, and a further proteolysis step using a single second protease or combination of second proteases. The invention also relates to identified epitopes and to antibodies which bind to epitopes that have been identified by methods of the invention.
    Type: Application
    Filed: October 6, 2017
    Publication date: February 6, 2020
    Applicant: OBLIQUE THERAPEUTICS AB
    Inventors: Owe ORWAR, Carolina TRKULJA, Max DAVIDSON, Jessica HÄGGLUND
  • METHODS OF IDENTIFYING EPITOPES
    Publication number: 20190194320
    Abstract: The present invention relates to methods of identifying an epitope on a protein that can be bound by an antibody. Methods of the invention typically involve a step of limited or restricted proteolysis of a protein and the identification of sites on the protein that are cut by the protease(s) used. The invention also relates to antibodies which bind to epitopes that have been identified by methods of the invention.
    Type: Application
    Filed: September 1, 2017
    Publication date: June 27, 2019
    Applicant: OBLIQUE THERAPEUTICS AB
    Inventors: Owe ORWAR, Carolina TRKULJA, Max DAVIDSON
  • PLASMA MEMBRANE VESICLES AND METHODS OF MAKING AND USING SAME
    Publication number: 20110143385
    Abstract: The instant invention provides plasma membrane vesicles, methods of making the same, and method of using the plasma membrane vesicles.
    Type: Application
    Filed: October 21, 2010
    Publication date: June 16, 2011
    Applicant: NANOXIS AB
    Inventors: Brigitte Bauer, Max Davidson, Owe Orwar, Anders Karlsson, Roger Karlsson
  • Device And Use Thereof
    Publication number: 20110091864
    Abstract: Disclosed herein is a device comprising at least one supporting solid surface comprising at least one membraneophilic region; a covering layer that is at least partially immobilized to the membraneophilic region, said covering layer consisting of (i) a surfactant membrane, (ii) a lipid mimicking polymer, (iii) a surfactant or emulsion system or (iv) a liquid crystal; and a substance included in or bound to, connected to or associated with the covering layer. Also disclosed are methods wherein the device is used and use of the device.
    Type: Application
    Filed: December 23, 2005
    Publication date: April 21, 2011
    Inventors: Anders Karlsson, Roger Karlsson, Johan Pihl, Mattias Karlsson, Owe Orwar, Tatiana Lobovkina, Max Davidson, Aldo Jesorka
  • Apple tree named 'Lady Laura'
    Publication number: 20080184402
    Abstract: A new apple variety distinguished by the amount and intensity of over-color of the fruit and the earlier coloration of the fruit.
    Type: Application
    Filed: July 25, 2006
    Publication date: July 31, 2008
    Inventors: Max Davidson, Grahame Davidson
  • Apple tree named ‘Lady Laura’
    Patent number: PP19826
    Abstract: A new apple variety distinguished by the amount and intensity of over-color of the fruit and the earlier coloration of the fruit.
    Type: Grant
    Filed: July 25, 2006
    Date of Patent: March 17, 2009
    Inventors: Max Davidson, Grahame Davidson